aethlon_8k-072810.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2010
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
|
Nevada
(State or other jurisdiction
of incorporation)
|
|
000-21846
(Commission File Number)
|
|
13-3632859
(IRS Employer
Identification Number)
|
| |
|
|
|
8910 University Center Lane, Suite 660
San Diego, California
(Address of principal executive offices)
|
|
92122
(Zip Code)
|
Registrant’s telephone number, including area code: (858) 459-7800
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
| |
|
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| |
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference is a description of the common stock of Aethlon Medical, Inc. (the “Company”). As permitted by guidance published by the Securities and Exchange Commission (the “Commission”), this description is being provided for purposes of Commission forms that require the incorporation by reference of a description of securities contained in a registration statement filed under the Securities Exchange Act of 1934, as amended.
|
ITEM 9.01
|
FINANCIAL STATEMENTS AND EXHIBITS.
|
|
EXHIBIT NO.
|
DESCRIPTION
|
| |
|
|
99.1
|
Description of Common Stock
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AETHLON MEDICAL, INC.
|
|
| |
|
|
|
|
|
By:
|
/s/ James A. Joyce |
|
| |
|
James A. Joyce
|
|
|
Dated: July 30, 2010
|
|
Chief Executive Officer
|
|
| |
|
|
|
EXHIBIT INDEX
|
EXHIBIT NO.
|
DESCRIPTION
|
| |
|
|
99.1
|
Description of Common Stock
|